Indexus Biomedical LLC is a medical device company located in the Research Triangle Park, North Carolina, USA.


At Indexus we are focused on delivering highly innovative and affordable solutions to the decentralized primary care laboratories that will dramatically increase access to much needed advanced in-vitro diagnostic testing for the patients.

Our flagship platform, the Indexus TriSense Dx system, currently under development, is an easy-to-use, compact, low-cost multifunction blood analyzer capable of performing automated hematology analysis, cellular immunoassays, and bead-based immunoassays on demand.


Indexus is funded by NIH (SBIR), NC Department of Commerce, North Carolina Biotechnology Center, and Angel Investors.

Indexus Biomedical LLC

2 Davis Drive

Durham, NC 27709


Phone: 919-824-0419

Email: info@indexusbiomed.com



Edited Image 2016-02-25 18-45-32

Chiranjit Deka, PhD


Chiranjit Deka (Chira), founder and CEO of Indexus Biomedical Inc., has over 20 years of experience in the IVD and biotechnology industry. An entrepreneur, innovator and commercial product developer, Chira has developed technologies and products in flow cytometry, hematology, immunoassay and molecular diagnostics. Prior to Indexus, he served as Vice President of Product Development at Advanced Liquid Logic (acquired by Illumina in 2013), Sr. Director of Engineering at Peoples Genetics Inc. (acquired by Beckman Coulter in 2003), and Head of Hematology Systems R&D at IDEXX Laboratory. Earlier he was with Beckman Coulter’s hematology division in Miami where he led the development of several new hematology and flow cytometry technologies for clinical diagnostic and life sciences research, and with Los Alamos National Laboratory devloping new flow cytometry technologies. Chira has written successful SBIR and other technology research grants for different companies leading up to over 3.25 million dollars in total awards. 

Greg A Ryan, MBA

Sr. Director, Finance 

Director of Sponsored Research Progmans


Greg Ryan has over 20 years of business development, financial consulting & management experience.  Prior to joining Indexus Biomedical, Greg worked for the Office of the Secretary of Defense, Acquisitions, Technology and Logistics where he helped develop financial management and accounting policies for the Department of Defense (DoD).  He has consulted for the North Carolina Military Business Center where he helped NC companies navigate and maximize business opportunities with the DoD and federal government.  As an entrepreneur, he launched a successful local service company in Durham, NC that continues to thrive in the regional health and fitness market. Greg manages Indexus Biomedical's finances, oversees the administration of the company's government sponsored research programs and manages the company’s overall administrative operations, including HR.  He is a graduate of Duke University’s Fuqua School of Business and is a Lieutenant Colonel in the US Marine Corps Reserves.


Jay earned his PhD in Pharmacology and postdoctoral fellowship training in molecular biology from Duke University Medical School. Jay has extensive experience in cell and molecular biology research and serves as the research and technology development lead focusing on reagent and assay development for the Indexus-H5F system. Jay is an expert in the design and development of reagents and methods for bead-based multiplexed immunoassays, automated hematology 5-part differential assays, and cellular immunophenotyping assays.

Jay Stringer, PhD

Director of Research and Technology Development, Reagents and Assays



Commercial Advisors

Clinical & Scientific Advisors

Professor Thomas Denny, MPhil

Professor of Medicine and Chief Operating Officer

Duke Human Vaccine Institute and

Center for HIV/AIDS Vaccine Immunology

Durham NC USA


Dr. John Schmitz, Ph.D.

Professor of Pathology and Laboratory Medicine, UNC Medical School

Director, Immunology, Flow Cytometry, Histocompatibility Laboratories

UNC Hospitals

Chapel Hill, NC USA


Dr. Philippa Sprinz, MD

Hasbro Children's Hospital, RIH

Former Director of Pediatric Hematology and Oncology, Boston Medical Center

Boston, MA USA


Dr. Scott Cram, Ph.D.

Director, Life Sciences Division (Retd.)

Los Alamos National Laboratory

Los Alamos, NM USA


Prof. Michael Bass, Ph.D.

Professor Emeritus

School of Optics, CREOL

University of Central Florida

Orlando, FL USA


Dr. Naba Kumar Hazarika, MD

Head of the Microbiology Department

Gauhati Medical College Hospital

Assam, INDIA


Dr. Pulin K Deka, MD

Former Chief Administrator and

Head of the Microbiology Department (Retd.)

Gauhati Medical College Hospital

Professor in charge of AIDS Surveillance Center, Dept. of Health, Govt. of Assam (Retd.)

Assam, INDIA


Indexus Biomedical LLC gratefully acknowledges funding and/or other suport from the following government and non-governmental autonomous organizations:


Mr. Jack T Ball Jr.

CEO, Solulink Inc.

Chief Commercial Officer, Accuri Cytometer

Ann Arbor, MI USA


Ms. Gloria Young, MBA

VP, HIV/AIDS Global Initiative, Becton Dickinson (BD)

Consultant, WHO, UNITAID


Dr. Robert Dodge, PhD.

VP, R&D (Retired), IDEXX Laboratory

Maine, USA


Dr. Jai Murthy, PhD

Former VP, Marketing & Sales,Metabolon Inc.

and Director of Global Product Management, Thermo Fisher Scientific, USA


Mr. Pranjal Sharma, MBA

Principal, Molbiogen Pvt. Ltd India

Former Sales Executive at Merck India Ltd, Biomerieux India & Roche Diagnostics India Pvt Ltd. 


Partnership and Collaborations

We seek out partnerships and strategic collaborations to share our technologies and product development expertise and create win-win relationships.